ICICI Prudential Mutual Fund decreased its stake in Hikal Limited from 3.24% to 2.41%, selling 10,22,934 shares.
A supplier of active ingredients, intermediates, and research services to companies in the pharmaceuticals, crop protection, and specialty chemicals sectors. Hikal operates manufacturing facilities across India that have been inspected and approved by leading multinational companies. The company maintains crop protection plants in Maharashtra, pharmaceutical manufacturing units in Karnataka and Gujarat, and research and development capabilities in Pune.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.
